NO20034723L - Anvendelse av proteinet UK114 eller fragmenter derav ved behandling og forebygging av endotoksisk sjokk - Google Patents

Anvendelse av proteinet UK114 eller fragmenter derav ved behandling og forebygging av endotoksisk sjokk

Info

Publication number
NO20034723L
NO20034723L NO20034723A NO20034723A NO20034723L NO 20034723 L NO20034723 L NO 20034723L NO 20034723 A NO20034723 A NO 20034723A NO 20034723 A NO20034723 A NO 20034723A NO 20034723 L NO20034723 L NO 20034723L
Authority
NO
Norway
Prior art keywords
fragments
protein
prevention
treatment
endotoxic shock
Prior art date
Application number
NO20034723A
Other languages
English (en)
Norwegian (no)
Other versions
NO20034723D0 (no
Inventor
Alberto Bartorelli
Pierferdinando Nicoletti
Alberto E Panerai
Original Assignee
Zetesis Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zetesis Spa filed Critical Zetesis Spa
Publication of NO20034723L publication Critical patent/NO20034723L/no
Publication of NO20034723D0 publication Critical patent/NO20034723D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Zoology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
NO20034723A 2001-04-10 2003-10-22 Anvendelse av proteinet UK114 eller fragmenter derav ved behandling og forebygging av endotoksisk sjokk NO20034723D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT2001MI000762A ITMI20010762A1 (it) 2001-04-10 2001-04-10 Uso della proteina uk114 o di suoi frammenti per il trattamento e la prevenzione dello shock endotossico
PCT/EP2002/003933 WO2002083161A1 (en) 2001-04-10 2002-04-09 Use of the protein uk114 or of fragments thereof for the treatment and prevention of the endotoxic shock

Publications (2)

Publication Number Publication Date
NO20034723L true NO20034723L (no) 2003-10-22
NO20034723D0 NO20034723D0 (no) 2003-10-22

Family

ID=11447468

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20034723A NO20034723D0 (no) 2001-04-10 2003-10-22 Anvendelse av proteinet UK114 eller fragmenter derav ved behandling og forebygging av endotoksisk sjokk

Country Status (22)

Country Link
US (1) US20040180835A1 (et)
EP (1) EP1377308A1 (et)
JP (1) JP2004526762A (et)
KR (1) KR20040000423A (et)
CN (1) CN1501807A (et)
BG (1) BG108246A (et)
BR (1) BR0208793A (et)
CA (1) CA2443726A1 (et)
CZ (1) CZ20032744A3 (et)
EE (1) EE200300489A (et)
HR (1) HRP20030815A2 (et)
HU (1) HUP0303798A3 (et)
IL (1) IL158333A0 (et)
IT (1) ITMI20010762A1 (et)
MX (1) MXPA03009228A (et)
NO (1) NO20034723D0 (et)
PL (1) PL367764A1 (et)
RU (1) RU2003130226A (et)
SK (1) SK12582003A3 (et)
WO (1) WO2002083161A1 (et)
YU (1) YU80003A (et)
ZA (1) ZA200307901B (et)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1244879B (it) * 1990-12-11 1994-09-12 Alberto Bartorelli Estratti da tessuti animali, utili in terapia e in diagnostica.
IT1270618B (it) * 1994-07-14 1997-05-07 Zetesis Spa Proteine ad attivita' antitumorale
IT1282608B1 (it) * 1996-02-13 1998-03-31 Zetesis Spa Sequenza oligonocleotidica da fegato di capra
WO1998011909A1 (en) * 1996-09-18 1998-03-26 Zetesis S.P.A. Use of proteins as agents against autoimmune diseases
IT1290828B1 (it) * 1997-03-25 1998-12-11 Zetesis Spa Uso di proteine estraibili da organi animali per la preparazione di medicamenti per il trattamento di condizioni patologiche
IT1298442B1 (it) * 1998-02-24 2000-01-10 Zetesis Spa Composizioni orali a basso dosaggio di proteine citotossiche

Also Published As

Publication number Publication date
SK12582003A3 (sk) 2004-03-02
US20040180835A1 (en) 2004-09-16
CN1501807A (zh) 2004-06-02
HRP20030815A2 (en) 2005-08-31
RU2003130226A (ru) 2005-02-10
ZA200307901B (en) 2004-10-11
EE200300489A (et) 2003-12-15
ITMI20010762A0 (it) 2001-04-10
MXPA03009228A (es) 2004-03-16
HUP0303798A3 (en) 2005-12-28
BR0208793A (pt) 2004-03-09
IL158333A0 (en) 2004-05-12
KR20040000423A (ko) 2004-01-03
CZ20032744A3 (en) 2004-05-12
ITMI20010762A1 (it) 2002-10-10
JP2004526762A (ja) 2004-09-02
CA2443726A1 (en) 2002-10-24
YU80003A (sh) 2006-05-25
PL367764A1 (en) 2005-03-07
WO2002083161A1 (en) 2002-10-24
BG108246A (bg) 2005-04-30
EP1377308A1 (en) 2004-01-07
HUP0303798A2 (hu) 2004-03-01
NO20034723D0 (no) 2003-10-22

Similar Documents

Publication Publication Date Title
NO20034169L (no) MCH-antagonister og deres anvendelse ved behandling av fedme
NO20043370L (no) N-pyrazinylfenylsulfonamider og deres anvendelse ved behandling av kemokinmedierte sykdommer
NO20032695D0 (no) Karboksamidderivater og deres anvendelse ved behandling av tromboemboliskesykdommer
NO20034437L (no) Gangliosid-assosierte rekombinante antistoffer og anvendelse derav ved diagnostikk og behandling av tumorer
NO20041203L (no) Human glukagonlignende peptid-1 etterligner og deres anvendelse i behandling av diabetes og relaterte tilstander.
NO20035611D0 (no) Sammensetning og fremgangsmåte for kontroll ved behandling av hydrokarbon
DE60222671D1 (de) Thienopyrimidinedione und deren verwendung in der behandlung von autoimmunerkrankungen
EP1603391A4 (en) METHOD OF USE OF COMPOSITIONS COMPRISING HIGH SHOCK PROTEINS OR ALPHA-2-MACROGLOBULIN IN THE TREATMENT OF CANCER AND INFECTION DISEASES
NO20044195L (no) Biofosfoninsyrer for behandling og prevensjon av osteoprose
DE60209486D1 (de) Pyranoindazole und ihre verwendung in der glaukombehandlung
NO20033443D0 (no) Anvendelse av CD-2-bindende midler ved behandling eller forebygging av hudlidelser
NO20025307D0 (no) Anvendelse av IL-18 inhibitorer til behandling og/eller forebygging av aterosklerose
EP1575601A4 (en) RECOMBINANT VACCINE VIRUSES EXPRESSING IL-15 AND METHODS OF USING THE SAME VIRUSES
IS6966A (is) Cýanó-tengd díhýdrópýrimídín efnasambönd og notkun þeirra við meðhöndlun sjúkdóma
IS6967A (is) Ný cýanó-tengd díhýdrópýrimídín efnasambönd og notkun þeirra við meðhöndlun sjúkdóma
NO20033498D0 (no) Fremgangsmåte for behandling og törking av trevirke
NO20020031D0 (no) Dihydrobenzodiazepiner og deres anvendelse ved behandling av dyslipidemi
NO20001412D0 (no) Sammensetninger og fremgangsmåter ved behandling av respiratoriske forstyrrelser
AU2002364171A8 (en) Materials and methods for the treatment or prevention of obesity
NO20054346D0 (no) Sammensetninger og fremgangsmater for forebygging og behandling av endotoksinrelaterte sykdommer og tilstander
NO20043029L (no) Karboksamidinderivater og deres anvendelse ved behandling av vaskulaere sykdommer
PT1381620E (pt) Dissacaridos hipersulfatados e metodos de utilizacao dos mesmos para o tratamento de inflamacoes
NO20034723D0 (no) Anvendelse av proteinet UK114 eller fragmenter derav ved behandling og forebygging av endotoksisk sjokk
AU2003287216A8 (en) Gb virus c and methods of treating viral infections
NO20004966D0 (no) Anvendelse av anti-gp-39-antistoff ved behandling og/eller reversering av lupus og assosiert nyresykdom

Legal Events

Date Code Title Description
RE Reestablishment of rights (par. 72 patents act)
FC2A Withdrawal, rejection or dismissal of laid open patent application